z-logo
open-access-imgOpen Access
Mortality in Children Receiving Growth Hormone Treatment of Growth Disorders: Data From the Genetics and Neuroendocrinology of Short Stature International Study
Author(s) -
Charmian A. Quigley,
Christopher J. Child,
Alan G. Zimmermann,
Ron G. Rosenfeld,
Leslie L. Robison,
Werner Blum
Publication year - 2017
Publication title -
the journal of clinical endocrinology and metabolism
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.206
H-Index - 353
eISSN - 1945-7197
pISSN - 0021-972X
DOI - 10.1210/jc.2017-00214
Subject(s) - medicine , idiopathic short stature , short stature , pediatrics , context (archaeology) , turner syndrome , population , small for gestational age , endocrinology , gestational age , growth hormone , pregnancy , hormone , paleontology , genetics , environmental health , biology
Although pediatric growth hormone (GH) treatment is generally considered safe for approved indications, concerns have been raised regarding potential for increased risk of mortality in adults treated with GH during childhood.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom